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Objective: To characterise a novel multifunctional pharmaceutical excipient and
investigate its effect on paracetamol release from tablets prepared by direct compression.
Methods: The excipient was prepared by co-processing gelatinized maize starch with
sodium carboxymethyl cellulose and microcrystalline cellulose in a ratio of 2:1:1, dried
and pulverized into powder. The excipient formulated was characterized using Fourier
transform infrared spectroscopy and differential scanning calorimetry. The excipient was
used to prepare batches of tablets by direct compression with drug-excipient ratios of 1:1,
1:2, 1:3 and 1:4. Parameters evaluated on tablets include crushing strength, friability and
in vitro dissolution studies.
Results: Differential scanning calorimetry analysis revealed a crystalline excipient while
Fourier transform infrared spectroscopy showed no interaction between the excipient and
paracetamol. Tablets from all the batches gave average crushing strength values between
3.47 and 4.88 kp. The 1:1 and 1:2 tablet batches were comparable to each other while 1:3
and 1:4 were also comparable to one another in their dissolution proﬁles. The dissolution
parameters of the 1:4 batch was faster with – m∞ (90.5%), t50% (3.5 min), t70% (11.6 min)
while that of ratio 1:1 was the least with – m∞ (48.6%), m5min (23.8%). Their release
kinetics followed a Korsmeyer–Peppas model with a super case-II transport mechanism.
Conclusions: The drug-excipient ratios of 1:3 and 1:4 gave pharmaceutically acceptable
tablets that met the British Pharmacopoeia speciﬁcations. The t50% value of the 1:4 batch
of tablets may ﬁnd its usefulness in formulating drugs for which a fast onset of action is
desired.1. Introduction
The science of drug formulation dates as far back as antiq-
uity, ﬁrst in the apothecaries and now in modern times, in
pharmaceutical industries, compounding pharmacies and
research and development laboratories. The aim has always been
to formulate a drug product that is acceptable, stable, easy to
administer, efﬁcacious, cheap and easy to formulate and that will
deliver drug in a desirable manner [1]. In this bid for easier and
cheaper methods of formulation, the pharmaceutical scientist isalways on the lookout for newer methods and ingredients or
excipients that will give a better result. It is important that
these newer formulation components do not alter the desired
features of the formulation e.g. drug release proﬁle,
bioavailability, clinical effectiveness, etc [2].
In the formulation of tablets, the drug and ingredients will
need to undergo granulation process to convert them into a state
that can be readily compressed into acceptable tablets. However,
direct compression (DC) method of tablet manufacture can be
used if these formulation components have the necessary degree
of ﬂuidity and compressibility [3].
A key component in the DC process is the excipients. They
must not only possess those properties which are necessary for
satisfactory tablet formulation but retain them when mixed
together especially with the active ingredients [4]. Excipients
provide a wide variety of functionalities such as betteran open access article under the CC BY-NC-ND
Table 1
Formula of prepared paracetamol tablets.
Ingredients Quantity (mg/tablet)
1:1 1:2 1:3 1:4
Paracetamol 100 100 100 100
Excipient X 100 200 300 400
Maize starch 100 100 100 100
Lactose 350 250 150 50
Total 650 650 650 650
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dosage forms, better tablet binding, better tablet disintegration
and better active pharmaceutical ingredients bioavailability [5].
The search and development of excipients with better and
improved physico-mechanical properties is gaining more atten-
tion with the formulation pharmacist and the pharmaceutical
companies who are always looking for ways to improve their
drug product [6]. No single excipient possesses all the desired
physico-mechanical properties for the development of a robust
drug delivery system. Hence, there is the need to have excipients
with multiple characteristics built into them such as better ﬂow,
low/no moisture sensitivity, superior compressibility and rapid
disintegration ability [7].
The aim of this research work was to formulate and char-
acterize a novel pharmaceutical excipient using the simple
method of co-processing and to determine its effect on release
proﬁle of paracetamol from tablets.
2. Materials and methods
2.1. Materials
Maize starch British Pharmacopoeia (BP), microcrystalline
cellulose (MCC) and sodium carboxymethyl cellulose were gifts
from Edo Pharmaceuticals, Edo State, Nigeria, a-lactose mon-
ohydrate was obtained from Fluka Chemical Corp., Milwaukee,
USA, and paracetamol powder was purchased from Nomagbon
Pharmaceuticals, Edo State, Nigeria. All other reagents used
were of analytical grade and water was double distilled.
2.2. Excipient preparation
The preparation of the excipient has been previously re-
ported [8]. Six grams of maize starch BP was weighed and
dispersed in distilled water at 32 C, to make a 10 mL slurry
in a 500 mL beaker. The slurry was well stirred to ensure
that all the powder was properly wetted. Freshly boiled water
at 100 C was then added to the slurry to reach the 200 mL
mark and stirred properly till a gel of uniform consistency
was formed. Sodium carboxyl methylcellulose (2 g) powder
was then dispersed in the gel, in little quantities at a time (to
prevent lump formation) and stirred continuously until an
even mixture was produced. Then, a mixture containing 2 g
of MCC in 5 mL of distilled water was added and stirred
until a smooth suspension of all three substances was
obtained. The suspension was then transferred into a
transparent heat resistant plastic container, spread thinly and
dried in the hot air oven at 60 C for 48 h. The resulting
ﬂakes were pulverized using a dry kitchen blender (Phillips,
Switzerland) and stored in an air tight container over silica
gel until use. The excipient so prepared was termed
“Excipient X”.
2.3. Differential scanning calorimetry (DSC)
characterization
DSC analysis was carried out using the Netzsch DSC 204 F1
Phoenix apparatus (Netzsch-Geratebau GmbH, Selb, Germany).
Four milligrams of the sample was weighed into aluminium
pans. The seals were pierced and calibration of the calorimeter
was done with indium and the purge gas was nitrogen. Heatingof the sample was carried out at the rate of 10 C per min from
30 to 350 C under nitrogen at a ﬂow rate of 70 mL/min. The
analysis was carried out on paracetamol, maize starch BP, so-
dium carboxyl methylcellulose, MCC and the tablet granules
containing Excipient X.
2.4. Fourier transform infra-red (FTIR) characterization
The FTIR analysis of the samples was carried out using
Fourier transform infrared spectrophotometer (Spectrum BX,
Perkin Elmer, Beaconsﬁeld, Bucks, England). The potassium
bromide pellet method was used; paracetamol powder, compo-
nents of Excipient X and the tablet granules were scanned at a
range of 4000–1000 cm−1.
2.5. Tablet formulation
Paracetamol tablets were prepared by DC using the formula
in Table 1. The different batches of the tablets containing drug-
Excipient X ratios of 1:1, 1:2, 1:3 and 1:4 were prepared by
weighing the appropriate quantities of paracetamol powder and
Excipient X into a mixer and dry mixed for 5 min. Maize starch
and lactose were added as disintegrant and ﬁller respectively and
the mixer operated for 5 min. The powder mix was compressed
into tablets using a single punch tableting machine (F3, Manesty
Machine Ltd., Liverpool, UK) at compression pressure of 32 kN.
The die volume was adjusted to compress tablets of uniform
weight by using powders weighing 650 mg. The tablets made
were then kept in air tight containers and stored in a desiccator
until evaluation.
2.6. Tablet crushing strength
The crushing strength (hardness) of ten tablets per batch was
determined by diametral compression using a motorized hard-
ness tester (Campbell Electronics, Model HT-30/50, Mumbai,
India). The mean hardness ± standard deviations were
calculated.
2.7. Friability test
The weight of ten tablets was determined on an electronic
balance (Ohaus Corporation, USA). The tablets were then
placed in the drum of a Friabilator (ERWEKA GmbH, Heu-
senstamm, Germany) revolving at 25 r/min which exposed the
tablets to rolling and repeated shock resulting from free fall
within the apparatus. After 4 min, the tablets were brought out,
de-dusted and reweighed. The weight was then recorded and
friability calculated as percentage loss in weight.
Table 2
Some physical parameters of the paracetamol tablet.
Batch Crushing strength (kp) Friability (%)
1:1 4.88 ± 0.57 1.70 ± 0.03
1:2 4.16 ± 0.32 1.30 ± 0.02
1:3 4.12 ± 1.40 0.90 ± 0.05
1:4 3.47 ± 1.43 0.60 ± 0.03
Figure 1. DSC of paracetamol (a), MCC (b), sodium carboxymethyl cel-
lulose (c), maize starch (d) and paracetamol granules (e) prepared with
excipient X.
Figure 2. FTIR of paracetamol (a), MCC (b), sodium carboxymethyl
cellulose (c), maize starch (d) and paracetamol granules (e) prepared with
excipient X.
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The dissolution proﬁles of the paracetamol tablets were
determined using the BP basket method for the various batches
of the tablets (Caleva ST7, G.B. Caleva Ltd., Dorset, UK). A
dissolution medium of 900 mL of 0.1 mol/L HCl solution
maintained at (37 ± 0.5) C with a basket revolution of 50 r/min
was used. A 5 mL volume of leaching ﬂuid was withdrawn at
predetermined time intervals and replaced with an equivalent
volume maintained at the same temperature (37 ± 0.5) C of the
dissolution medium. The samples were ﬁltered and diluted with
an equal volume of 0.1 mol/L HCl. This was continued for
60 min. The absorbances of the resulting solutions were
measured spectrophotometrically at lmax of 245 nm (T70, PG
Instruments Ltd., Leicestershire, England). The percentage
drug released at each time interval was determined using the
equation from the standard calibration plot obtained for the
pure drug. A minimum of triplicate determinations were carried
out for all experiments and the results were reported as
mean ± SD.
2.9. Release kinetics
The dissolution data were analysed on the basis of zero
order, (cumulative amount of drug released vs time), ﬁrst order
rate (log cumulative amount of drug remaining vs time),
Higuchi model (cumulative amount of drug released vs square
root of time) and Korsmeyer–Peppas model (log cumulative
amount of drug released vs log of time). These are the most
frequently reported kinetics of drug release from drug particles
and their solid dosage forms [9,10]. The correlation coefﬁcient
(r2) for each rate order was calculated. The dissolution
proﬁle was considered to follow a particular rate order if the
r2 value was  0.99 [11].
2.10. Statistical analysis
All data obtained were expressed as mean ± SD. The sta-
tistical difference of the paracetamol release data for the batches
was accessed by means of the student t-test (P < 0.05) using
GraphPad InStat software version 3.36.
3. Results
3.1. Thermal analysis
Figure 1 shows the DSC thermograms of pure paracetamol
powder, MCC powder, sodium carboxymethyl cellulose pow-
der, maize starch powder and the tablet granules. Paracetamol
thermogram shows a sharp endothermic peak, corresponding to
its melting point (169 C).
3.2. FTIR
The FTIR spectrum of pure paracetamol powder showed
characteristic peaks at 1227.00 cm−1, 1636.42 cm−1 and
3171.00 cm−1. These peaks observed for paracetamol remained
unchanged when compared with the spectral data of the granules
(Figure 2).3.3. Physical parameters of the tablets
Table 2 shows some physical parameters of the paracetamol
tablets formulated. All the tablets from all the batches gave mean
crushing strength values between 3.47 and 4.88 kp; hardness
values greater than or equal to 4 kp is considered to be the
minimum for a satisfactory tablet [12].
Table 4
Correlation coefﬁcient (r2) and release rate constants (k) of the dissolution studies.
Batch Zero order First order Higuchi Korsemeyer–Peppas
r2 k r2 k r2 k r2 k n
1:1 0.0410 1.0183 0.7203 0.0082 0.8665 5.5783 0.9101 0.2452 1.2447
1:2 0.1810 1.1740 0.7293 0.0099 0.8477 6.2001 0.9708 0.1892 1.3891
1:3 0.4790 1.7824 0.7501 0.0219 0.7545 8.8106 0.8494 0.1288 1.6638
1:4 0.6320 1.9627 0.7709 0.0280 0.7146 9.4080 0.8387 0.1053 1.7431
Figure 3. Percentage amounts of paracetamol released from different tablet
formulations.
Table 3
A comparison of the empirical release data of paracetamol tablets.
Parameters evaluated Batch
1:1 1:2 1:3 1:4
m∞ (%) 48.6 54.5 84.9 90.5
m5min (%) 23.8 34.7 59.2 68.5
t50% (min) – 42.0 4.2 3.5
t70% (min) – – 34.0 11.6
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The release proﬁles of the various batches of the paracetamol
tablets were presented in Figure 3. A comparison of the
empirical release data obtained from these curves was presented
in Table 3. It can be observed that the batches of tablets of ratio
1:1 and 1:2 gave a comparable release proﬁle with each other
while ratios 1:3 and 1:4 also compared with each other
(Figure 3).
Correlation coefﬁcients (r2 values) are presented in Table 4
which showed that the drug release was most consistent with the
Korsemeyer–Peppas model (n > 1), indicating that drug release
was essentially by a super case-II transport mechanism [13].
4. Discussion
The sharp peak which appears as a spike is indicative of the
purity and crystallinity of paracetamol. On the other hand, the
thermogram of the tablet granules containing Excipient X and
paracetamol together showed three sharp endothermic peakswith the characteristic peak of pure paracetamol at the middle.
Excipient X appears to be more crystalline than amorphous due
to the pre-gelled and dried starch component interaction with
MCC, which could have facilitated its increase in tablet binding
activity and subsequent fast disintegrating action. The broad
trough manifested by samples (b), (c) and (d) before 100 C is
probably as a result of loss of moisture. The FTIR spectra ruled
out the possibility of chemical interaction and complex forma-
tion between paracetamol and Excipient X during the mixing
and tableting processes.
The friability values of the tablets increased with decreasing
concentrations of Excipient X (Table 2). However, only tablets of
two batches (1:3 and 1:4) met the BP speciﬁcation of a maximum
loss of 1% of the mass of the tablets tested or a 0.8%–1.0% loss in
weight of the tested tablets without capping, lamination or
breaking up in the course of the test [14,15]. The crushing strength
of a tablet can markedly affect the release rate of a drug [16].
Usually, an increase in crushing strength of a tablet is
accompanied by a decrease in release rate, due to a decrease in
tablet porosity [17]. The change in crushing strength amongst the
batches of tablets studied could be the reason for the differences
in their release proﬁles. Though the crushing strength of the 1:4
batch of tablets did not meet the required minimum value of
hardness, this can be remedied by increasing the compression
pressure of the tablets as long as this does not adversely affect
the drug release characteristics of the tablet.
In vitro dissolution data implies that, only batches 1:3 and 1:4
tablets met the BP speciﬁcation which states that [15], 70% of the
uncoated tablet drug should dissolve within 40 min. Anotherimportant parameter from the release studies is the t50% value
which is very important in formulating drugs that may be
needed for fast onset of action. This tells the time at which
50% of the drug was dissolved, which means that in less than
5 min, 50% of the drug from batches 1:3 and 1:4 tablets was
already available for absorption.
Excipient X in drug-excipient ratios of 1:3 and 1:4 gave
pharmaceutically acceptable tablets that met the BP speciﬁca-
tions. The t50% value of the 1:4 batch of tablets may ﬁnd its
usefulness in formulating drugs for which a fast onset of action
is desired.
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